CTRI/2018/09/015814招募中未知
A RANDOMIZED DOUBLE-BLIND ACTIVE CONTROLLED CLINICAL TRIAL TO COMPARE THE EFFECT OF USE OF ADHESIVES ON THE CLINICAL OUTCOME IN CLASS V RESTORATIONS USING CENTION N , A DIRECT FILLING ALKASITE MATERIAL & PACKABLE GLASS IONOMER CEMENT IN CHILDREN AND YOUNG ADULTS
DR HIMANSHU AERA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)5-14 year old individual (both males and females) of districts of Uttarakhand.
- •2)Participants who have bilateral class V cavities in anterior teeth/premolars in primary/mixed /permanent dentition.
- •3)Individuals with a no systemic illness or psychological disorder of any kind
- •4)Individuals who do not have any removable appliance where the teeth in concern act as abutment tooth.
- •5)Individuals who do not have any malocclusion or TMJ related disorder.
- •6)The teeth in question should be periodontally sound and without any pulpal pathology.
- •7)Individuals who fulfill the research criteria and are ready to give the consent to participate in the study are considered for the study.
排除标准
- •1)Children below the age of 5years and above the age of 14 years.
- •2)Participants who refuse to participate in the study.
- •3)Subjects who are uncooperative for clinical examination during the study.
- •4)Subjects with any type of severe systemic disease or hypoplastic teeth or with persistent faulty oral habits.
- •5)Individuals with periodontally compromised teeth or pulpally involved anterior teeth / premolars.
- •6)Individuals with missing posterior teeth or malocclusion or TMJ disorder.
- •7)Individuals who canâ??t comply for a follow up of upto 2 years.
研究者
相似试验
进行中(未招募)
3 期
Study to determine the efficacy and safety of Dexlansoprazole in Gastroesophageal Reflux patientsCTRI/2012/01/002373Cipla Ltd242
已完成
不适用
O DISPONIBLEPER-042-10Boehringer Ingelheim,105
招募中
不适用
A DOUBLE-BLIND, RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY TO COMPARE EFFICACY AND SAFETY OF CT-P16 AND EU-APPROVED AVASTIN AS FIRST-LINE TREATMENT FOR METASTATIC OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCERPER-043-18CELLTRION, INC.,20
已完成
不适用
OT AVAILABLEPER-047-10GlaxoSmithKline,36
尚未招募
1 期
A STUDY TO KNOW THE ADVANTAGE OF USING LOW DOSE SPINAL DRUG IN ANORECTAL SURGERIESCTRI/2023/10/058646K R HOSPITA
